PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
iHealthcareAnalyst, Inc.

Press Release


Receive press releases from iHealthcareAnalyst, Inc.: By Email RSS Feeds:

Psoriasis Treatment Market by Drug Classes, Therapies, Distribution Channel and Forecast to 2021, Upcoming Report by iHealthcareAnalyst, Inc.


Psoriasis Treatment Market by Drug Class (Interleukin Blockers, TNF Inhibitors, Vitamin D Analogues or Combinations, Others), Therapy Type (Systemic Therapeutic Drugs, Topical Therapeutic Drugs, Combinations, Others), Distribution Channel (Hospital Pharmacy, Online Sales, Retail Pharmacy, Others) and Forecast 2017-2021.

Maryland Heights, MO, April 23, 2017 --(PR.com)-- Psoriasis is a long-lasting autoimmune disease which is characterized by patches of abnormal skin. It is often diagnosed or at least suspected on the basis of its appearance and distribution. There is no cure for psoriasis, however, various treatments can help control the symptoms. Topical treatments such as form of lotions, foams, creams, ointments, gels, and shampoos containing steroids, tar preparations, and calcium- modulating drugs are very useful because they are relatively safe, fairly effective, and can be applied directly to the affected skin. Most oral medications act by targeting portions of the immune system. Phototherapy or light therapy, involves exposing the skin to ultraviolet light on a regular basis and under medical supervision. Biologic drugs are usually prescribed for moderate to severe psoriasis and psoriatic arthritis that has not responded to other treatments. Treatments for more advanced psoriasis include narrow-band ultraviolet B (UVB) light, psoralen with ultraviolet A (UVA) light retinoids (isotretinoin [Accutane, Claravis], acitretin [Soriatane]), methotrexate (particularly for arthritis), cyclosporine (Neoral, Sandimmune), infliximab (Remicade), etanercept (Enbrel), adalimumab (Humira), apremilast (Otezla), and secukinumab (Cosentyx). Currently, calcineurin inhibitors such as tacrolimus (Prograf) and pimecrolimus (Elidel) are approved only for the treatment of atopic dermatitis. Vitamin D analogues such as Calcipotriene (Dovonex) slow down the growth of skin cells.

Browse Psoriasis Treatment Market by Drug Class (Interleukin Blockers, TNF Inhibitors, Vitamin D Analogues or Combinations, Others), Therapy Type (Systemic Therapeutic Drugs, Topical Therapeutic Drugs, Combinations, Others), Distribution Channel (Hospital Pharmacy, Online Sales, Retail Pharmacy, Others) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/psoriasis-treatment-market/

The global psoriasis treatment market segmentation is based on drug class (interleukin blockers, TNF inhibitors, vitamin d analogues or combinations, others), therapy type (systemic therapeutic drugs, topical therapeutic drugs, combinations, others), distribution channel (hospital pharmacy, online sales, retail pharmacy, others).

The global psoriasis treatment market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global psoriasis treatment market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global psoriasis treatment market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.

Major players operating in the global psoriasis treatment market and profiled in this report include AbbVie, Inc., Amgen, Inc., AstraZeneca, Biogen, Eli Lilly & Company, Johnson & Johnson, LEO Pharma A/S, Merck & Co., Inc., Novartis AG, and Pfizer, Inc.

1. Drug Class
1.1. Interleukin Blockers
1.2. TNF Inhibitors
1.3. Vitamin D Analogues or Combinations
1.4. Others

2. Therapy Type
2.1. Systemic Therapeutic Drugs
2.2. Topical Therapeutic Drugs
2.3. Combinations
2.4. Others

3. Distribution Channel
3.1. Hospital Pharmacy
3.2. Online Sales
3.3. Retail Pharmacy
3.4. Others

4. Geography (Region, Country)
4.1. North America (U.S., Canada)
4.2. Latin America (Brazil, Mexico, Rest of LA)
4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.4. Asia Pacific (Japan, China, India, Rest of APAC)
4.5. Rest of the World

5. Company Profiles
5.1. AbbVie, Inc.
5.2. Amgen, Inc.
5.3. AstraZeneca
5.4. Biogen
5.5. Eli Lilly & Company
5.6. Johnson & Johnson
5.7. LEO Pharma A/S
5.8. Merck & Co., Inc.
5.9. Novartis AG
5.10. Pfizer, Inc.

To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/psoriasis-treatment-market/

About Us

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com
Contact Information
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 500-7508
Contact
https://www.ihealthcareanalyst.com/

Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc.
Promote Your Business